p(21WAF1/CIP1) expression in breast cancers: associations with p53 and outcome (Q38464269)

3 September 2017

title

p(21WAF1/CIP1) expression in breast cancers: associations with p53 and outcome (English)

1 reference

3 September 2017

Thor AD

1

1 reference

3 September 2017

Liu S

2

1 reference

3 September 2017

Moore DH 2nd

3

1 reference

3 September 2017

Shi Q

4

1 reference

3 September 2017

Edgerton SM

5

1 reference

3 September 2017

language of work or name

English

0 references

publication date

1 May 2000

1 reference

Breast Cancer Research and Treatment

3 September 2017

published in

1 reference

3 September 2017

volume

61

1 reference

3 September 2017

issue

1

1 reference

3 September 2017

page(s)

33-43

1 reference

Oncogenes and tumor growth factors in breast cancer. A minireview

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006455526894

Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006455526894

Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006455526894

Accumulation of p53 Tumor Suppressor Gene Protein: An Independent Marker of Prognosis in Breast Cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006455526894

p53 as a prognostic factor in stage I breast cancer. South-East Sweden Breast Cancer Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006455526894

p53 and P-glycoprotein are often co-expressed and are associated with poor prognosis in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006455526894

Mutation detection by highly sensitive methods indicates that p53 gene mutations in breast cancer can have important prognostic value

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006455526894

Prognostic significance of TP53 alterations in breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006455526894

p21 is a universal inhibitor of cyclin kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006455526894

Absence of p21 expression is associated with abnormal p53 in human breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006455526894

Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006455526894

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006455526894

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006455526894

The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006455526894

Cancer. p53, guardian of the genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006455526894

The p21 cyclin-dependent kinase inhibitor suppresses tumorigenicity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006455526894

Cell-cycle control and its watchman.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006455526894

Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006455526894

Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006455526894

New tumor suppressor may rival p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006455526894

7 January 2021

Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006455526894

7 January 2021

Cancer prognostics: past, present and p27

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006455526894

7 January 2021

Node negative breast carcinoma: hyperprolactinemia and/or overexpression of p53 as an independent predictor of poor prognosis compared to newer and established prognosticators

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006455526894

7 January 2021

p21(Waf1/Cip1) and p53 protein expression in breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006455526894

7 January 2021

p53 status and the efficacy of cancer therapy in vivo

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006455526894

7 January 2021

WAF1/CIP1 protein expression in human breast tumors

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006455526894

7 January 2021

Comparison of mitotic index, in vitro bromodeoxyuridine labeling, and MIB-1 assays to quantitate proliferation in breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006455526894

7 January 2021

p53 mutations, another breast cancer prognostic factor

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006455526894

7 January 2021

Identifiers

DOI

10.1023/A:1006455526894

1 reference

Dimensions Publication ID

3 September 2017

1014473686

0 references

Fatcat ID

release_i6ikhzolwnagtlzn466363hnyi

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/i6ikhzolwnagtlzn466363hnyi

24 November 2022

mapped directly with Wikidata item

1 reference